BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2986153)

  • 21. Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs.
    Schwartz J; Liard JF; Ott C; Cowley AW
    Am J Physiol; 1985 Nov; 249(5 Pt 2):H1001-8. PubMed ID: 3840655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma atrial natriuretic factor during chronic thoracic inferior vena caval constriction.
    Paganelli WC; Cant JR; Pintal RR; Kifor I; Barger AC; Dzau VJ
    Circ Res; 1988 Feb; 62(2):279-85. PubMed ID: 2962784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin.
    Pucci ML; Lin L; Nasjletti A
    J Pharmacol Exp Ther; 1992 Apr; 261(1):240-5. PubMed ID: 1560371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma vasopressin in blood pressure homeostasis and in experimental renal hypertension.
    Pullan PT; Johnston CI; Anderson WP; Korner PI
    Am J Physiol; 1980 Jul; 239(1):H81-7. PubMed ID: 7396022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of vasopressin blockade on blood pressure during water deprivation in intact and baroreceptor-denervated conscious dogs.
    Gregory LC; Quillen EW; Keil LC; Chang D; Reid IA
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E490-5. PubMed ID: 3128117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal blockade to angiotensin II in acute and chronic sodium-retaining states.
    Slick GL; DiBona GF; Kaloyanides GJ
    J Pharmacol Exp Ther; 1975 Nov; 195(2):185-93. PubMed ID: 1185590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal effects of specific antagonists of arginine vasopressin in dogs.
    Yamada H; Yukimura T; Ito K; Takenaga T; Yamashita Y; Miura K; Yamamoto K
    Jpn J Pharmacol; 1991 Jan; 55(1):19-25. PubMed ID: 1828278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of vasopressin in cardiovascular and neurohormonal responses to intracerebroventricular hypertonic NaCl.
    Kawano Y; Ferrario CM
    Jpn Heart J; 1990 Mar; 31(2):237-44. PubMed ID: 1972413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A V1 vasopressin receptor antagonist has nonspecific neurodepressant actions in the spinal cord.
    Porter JP; Brody MJ
    Neuroendocrinology; 1986; 43(1):75-8. PubMed ID: 3012394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence against a pressor role for vasopressin in spontaneous hypertension.
    Sladek CD; Blair ML; Mangiapane M
    Hypertension; 1987 Apr; 9(4):332-8. PubMed ID: 2951326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line.
    Nambi P; Whitman M; Gessner G; Aiyar N; Crooke ST
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8492-5. PubMed ID: 2430290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
    Doursout MF; Chelly JE; Hartley CJ; Szilagyi J; Montastruc JL; Buckley JP
    J Pharmacol Exp Ther; 1988 Aug; 246(2):591-6. PubMed ID: 2969978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of indomethacin, renal denervation, and propranolol on plasma renin activity in conscious dogs with chronic thoracic caval constriction.
    Echtenkamp SF; Davis JO; DeForrest JM; Rowe BP; Freeman RH; Seymour AA; Dietz JR
    Circ Res; 1981 Aug; 49(2):492-500. PubMed ID: 7018734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary vasoactive effects of exogenous and endogenous AVP in conscious dogs.
    Nyhan DP; Geller HS; Goll HM; Murray PA
    Am J Physiol; 1986 Nov; 251(5 Pt 2):H1009-16. PubMed ID: 3022606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of vasopressin and the sympathetic nervous system in the cardiovascular response to vagal cold block in the conscious dog.
    Hasser EM; Haywood JR; Johnson AK; Bishop VS
    Circ Res; 1984 Oct; 55(4):454-62. PubMed ID: 6148158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin V1-receptor blockade lowers arterial blood pressure in young conscious Long-Evans rats.
    Obika LF; Laycock JF
    Q J Exp Physiol; 1989 May; 74(3):371-4. PubMed ID: 2526346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal response to atrial natriuretic factor in conscious dogs with caval constriction.
    Freeman RH; Davis JO; Vari RC
    Am J Physiol; 1985 Apr; 248(4 Pt 2):R495-500. PubMed ID: 3157329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of vasopressin on renal blood flow and its distribution in the rat.
    Azzawi SA; Shirley DG
    J Physiol; 1983 Aug; 341():233-44. PubMed ID: 6688636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.